INDIAN MARKET
 
INTERNATIONAL BUSINESS
 
 
The broad spectrum
ß-lactamase inhibitor

Inhibits all clinically
significant
ß-lactamases
  • Does not induce chromosomally mediated ß-lactamase production
  • Reduces MICs of cefoperazone by 4 to 28 fold
  • Expands the spectrum of activity of ampicillin / cefoperazone
ß-lactamases
Even BIGGER threat
93% Anaerobes
40% Gram -ve aerobes
23% Gram +ve aerobes
Found producing ß-lactamases